Edwards Lifesciences Corporation diagnostics interface makes it easy to digest most current publicly released information about Edwards Lifesciences as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Edwards Lifesciences price relationship with some important fundamental indicators such as market cap and management efficiency.
The company has Price/Earnings To Growth (PEG) ratio of 1.94. Edwards Lifesciences Corporation had not issued any dividends in recent years. This company had 2:1 split on 2015-12-14. Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. To learn more about EDWARDS LIFESCIEN call Michael Mussallem at 949 250-2500 or check out www.edwards.com.
Edwards Lifesciences Alerts
Edwards Lifesciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its debt commitments
The company currently falls under 'Large-Cap' category with market capitalization of 25.39 B.
The company has Net Profit Margin (PM) of 22.47 % which may suggest that it has a good control over its expenditures, executes well on its competitive polices, or have a solid pricing strategies. This is very large. Likewise, it shows Net Operating Margin (NOM) of 29.97 % which signify that for every $100 of sales it has a net operating income of 0.3.
Edwards Lifesciences Corporation has Return on Asset (ROA) of 12.64 % which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 25.45 % which means that it produced $25.45 on every 100 dollars invested by current stockholders.
Edwards Lifesciences Corporation shows Coefficient Of Variation of 426.24, Mean Deviation of 0.8435 and Downside Deviation of 0.8265. Edwards Lifesciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Edwards Lifesciences Corporation which can be compared to its rivals. Please confirm Edwards LifesciencesInformation Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to decide if Edwards Lifesciences is priced favorably providing market reflects its regular price of 120.49 per share. Given that Edwards Lifesciences has Jensen Alpha of 0.1074, we urge you verify Edwards Lifesciences Corporation prevailing market performance to make sure the company can sustain itself at future point.
Edwards Lifesciences Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Edwards Lifesciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Edwards Lifesciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.